世界のRNAi治療薬市場の価値は、2026年に11.5億ドルに達し、2022年から2026年までは10.19％のCAGRで拡大する見込みです。この市場の主な推進要因としては、オンコロジー医薬品の使用の上昇、加速している感染症の増加率、高齢者人口の増加、神経変性疾患の有病率の増加、RNAi治療薬における共同研究および関連する取引の進展などが挙げられます。一方で、RNAi治療薬のドラッグデリバリーに関連した複雑さ、RNA干渉を用いた治療薬の高額な開発コスト、厳格な規制要件などが成長の妨げとなります。いくつかの注目すべき動向としては、個別化医療の普及拡大、HTSおよびケロイド治療の代替としてのRNAi治療法の急増、分子診断における用途の拡大などがあります。
世界市場は、分子の種類別、用途別、エンドユーザー別に分類されています。分子の種類別には低分子干渉RNA（siRNA）とマイクロRNA（miRNA）に分類されます。用途別には、オンコロジー、呼吸器疾患、神経疾患、肝疾患、自己免疫疾患、その他の疾患に分けられます。一方、エンドユーザー別には、研究＆学術研究所と病院＆診断研究所に分類されます。
目次
1. Market Overview
1.1 Introduction
1.2 Different Classes of RNA Therapeutics
1.3 Major Pathways of RNAi
1.4 Various Small RNA Isoforms related to RNAi
1.5 Key Features of RNAi Therapeutics
1.6 Comparison of RNAi Treatments against Other Treatment Classes
1.7 Platform Comparison of RNAi Therapeutics
1.8 Applications of RNAi in Vivo
2. Impact of COVID-19
2.1 Rapid Spread of Coronavirus
2.2 Growth in COVID-19 R&D Funding
2.3 RNA Vaccine Development for COVID-19
3. Global Market Analysis
3.1 Global RNAi Therapeutics Market by Value
3.2 Global RNAi Therapeutics Market Forecast by Value
3.3 Global RNAi Therapeutics Market by Molecule Type
3.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market by Value
3.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Value
3.3.3 Global Small Interfering RNA (siRNA) Therapeutics Market by Type
3.3.4 Global Small Interfering RNA (siRNA) Therapeutics Type Market by Value
3.3.5 Global Small Interfering RNA (siRNA) Therapeutics Type Market Forecast by Value
3.3.6 Global MicroRNA (miRNA) Therapeutics Market by Value
3.3.7 Global MicroRNA (miRNA) Therapeutics Market Forecast by Value
3.4 Global RNAi Therapeutics Market by Application
3.4.1 Global RNAi Therapeutics Application Market by Value
3.4.2 Global RNAi Therapeutics Product Market Forecast by Value
3.5 Global RNAi Therapeutics Market by End-Users
3.5.1 Global RNAi Therapeutics End-User Market by Value
3.5.2 Global RNAi Therapeutics End-User Market Forecast by Value
3.6 Global RNAi Therapeutics Market by Region
4. Regional Market Analysis
4.1 North America
4.1.1 North America RNAi Therapeutics Market by Value
4.1.2 North America RNAi Therapeutics Market Forecast by Value
4.1.3 The U.S. RNAi Therapeutics Market Forecast by Value
4.2 Europe
4.2.1 Europe RNAi Therapeutics Market by Value
4.2.2 Europe RNAi Therapeutics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific RNAi Therapeutics Market by Value
4.3.2 Asia Pacific RNAi Therapeutics Market Forecast by Value
4.4 RoW
4.4.1 RoW RNAi Therapeutics Market by Value
4.4.2 RoW RNAi Therapeutics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Utilization in Oncology Pharmaceuticals
5.1.2 Accelerating Growth Rates of Infectious Diseases
5.1.3 Enlarging Geriatric Population
5.1.4 Increasing Prevalence of Neurodegenerative Disorders
5.1.5 Progress in Collaborations & Associated Deals in RNAi Therapeutics
5.1.6 Expanding Research & Development Activities
5.2 Key Trends and Developments
5.2.1 Growing Popularity of Personalized Medicine
5.2.2 Surging Preference as an Alternative for HTS & Keloids Treatment
5.2.3 Escalating Applications in Molecular Diagnostics
5.2.4 Development of RNAi Therapeutics
5.3 Challenges
5.3.1 Complexity Associated with the Delivery of RNAi Therapeutics
5.3.2 High Development Cost of RNA Interference-Based Therapeutics
5.3.3 Stringent Regulatory Requirements
6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
7. Company Profiles
7.1 Sanofi S.A. (Genzyme Corporation)
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Alnylam Pharmaceuticals Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Arrowhead Pharmaceuticals Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Arbutus Biopharma Corporation
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Benitec Biopharma Ltd.
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Sirnaomics, Ltd.
7.6.1 Business Overview
7.6.2 Business Strategies
List of Figures
Schematic Illustration of Different Classes of RNA Therapeutics
RNA Interference Therapeutic Process
Various Small RNA Isoforms related to RNAi
Key Features of RNAi Therapeutics
Applications of RNAi in Vivo
Number of Cumulative Cases of Coronavirus (COVID-19) Worldwide (2020)
COVID-19 R&D Funding by Major Countries (2020)
mRNA Vaccine in Development for COVID-19
Global RNAi Therapeutics Market by Value (2017-2021)
Global RNAi Therapeutics Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by Molecule Type (2021)
Global Small Interfering RNA (siRNA) Therapeutics Market by Value (2017-2021)
Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Value (2022-2026)
Global Small Interfering RNA (siRNA) Therapeutics Market by Type (2021)
Global Small Interfering RNA (siRNA) Therapeutics Type Market by Value (2017-2021)
Global Small Interfering RNA (siRNA) Therapeutics Type Market Forecast by Value (2022-2026)
Global MicroRNA (miRNA) Therapeutics Market by Value (2017-2021)
Global MicroRNA (miRNA) Therapeutics Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by Application (2021)
Global RNAi Therapeutics Application Market by Value (2017-2021)
Global RNAi Therapeutics Product Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by End-Users (2021)
Global RNAi Therapeutics End-User Market by Value (2017-2021)
Global RNAi Therapeutics End-User Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by Region (2021)
North America RNAi Therapeutics Market by Value (2017-2021)
North America RNAi Therapeutics Market Forecast by Value (2022-2026)
The U.S. RNAi Therapeutics Market Forecast by Value (2020-2026)
Europe RNAi Therapeutics Market by Value (2017-2021)
Europe RNAi Therapeutics Market Forecast by Value (2022-2026)
Asia Pacific RNAi Therapeutics Market by Value (2017-2021)
Asia Pacific RNAi Therapeutics Market Forecast by Value (2022-2026)
RoW RNAi Therapeutics Market by Value (2017-2021)
RoW RNAi Therapeutics Market Forecast by Value (2022-2026)
Oncology Pharmaceuticals Market in the U.S. and China (2020-2030)
Global Growth Rate of Infectious Diseases Forecast (2017-2022)
Global Population 65 Years and Above (2017-2021)
Worldwide Projections of Alzheimer’s Disease Prevalence (2015-2040)
Global Personalized Medicine Market (2018-2022)
Market Size of Hypertrophic Scars (HTS) & Keloids Treatments (2020-2030)
Global Molecular Diagnostics Market (2021-2026)
Sanofi S.A. Net Sales and Net Income (2017-2021)
Sanofi S.A. Net Sales by Segment (2021)
Sanofi S.A. Net Sales by Region (2021)
Alnylam Pharmaceuticals Inc. Revenue and Net Loss (2017-2021)
Alnylam Pharmaceuticals Inc. Revenue by Product (2021)
Arrowhead Pharmaceuticals Inc. Revenue & Net Income (Loss) (2017-2021)
Arbutus Biopharma Corporation Revenue and Net Loss (2017-2021)
Benitec Biopharma Ltd. Sales and Net Income (2017-2021)
List of Tables
Comparison of RNAi Treatments against Other Treatment Classes
Platform Comparison of RNAi Therapeutics
Deals in RNAi Therapeutics (2019-2021)
Approved RNAi Therapeutics (2018-2020)
Revenue Comparison of Key Players (2021)
Market Capitalization Comparison of Key Players (2022)
R&D Comparison of Key Players (2021)
